Prior studies using Markov chain models have typically focused on patient outcomes rather than cancer diagnosis endpoints (23, 26, 47), diverging from our study’s focus on prevention through large-scale screening to identify BRCA1/2 carriers and reduce cancer incidence probability through intensive follow-up and intervention. Here, BRCA1 is linked to cancer.